| 23/01/2013 | Cheek augmentation improves feeling of attractiveness and enhances confidence |
Aesthetic fillers aim to rejuvenate the ageing face, but the true end goal is to help patients feel better about their appearance. Cheek augmentation seems to elicit immediate recognition of an improved appearance.
In a recent study Dr. Amy Forman-Taub of the NorthWestern University Medical School in Chicago explored the connection between improving one's perception of self-attractiveness through the use of dermal fillers and the objective enhancement of the patient's good looks. |
| |
| |
| read article |
|
|
| |
| |
| |
| 16/12/2012 | Esthetique-Shop is open! |
When we opened our clinic we decided to offer to our patients a limited range of cosmeceuticals which are sometimes hard to find in the retail business. Cosmeceuticals are usually not sold by beauticians or perfumeries; rather by pharmacies and doctors. Our suppliers of medical products were found to be also importing and distributing a number of cosmeceutical brands, which we studied, tested and out of which we made a selection. The result of that selection can now be found on our new website: www.esthetique-shop.com. |
| |
| |
| read article |
|
|
| |
| |
| |
| 09/12/2012 | Teosyal® Redensity [II] for treatment of eye circles |
After the successful launch in August 2012 of Teosyal® Redensity [I] - combining dermal filling and mesotherapy techniques - and after 9 years of research and clinical trials, Teoxane Laboratories in Geneva introduce a brand new product to the aesthetic medicine market, specifically developed to treat the difficult and sensitive area around the eyes. |
| |
| |
| read article |
|
|
| |
| |
| |
| 22/08/2012 | Teosyal Redensity: a new light reflecting treatment |
Teosyal® Redensity [I] is a new concept, developed by Teoxane Laboratories in Geneva, which combines dermal filling techniques and mesotherapy to restore the skin’s ability to reflect light. It is a simple and effective protocol in 3 sessions at 3 weeks intervals which gives visible and cumulative results from the first injection session. |
| |
| |
| read article |
|
|
|
| |
| |
| |
| First | Previous 1/3 Next | Last |
|
|